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Pulmonary pericytes regulate lung morphogenesis
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Blood vessels are essential for blood circulation but also control organ growth, homeostasis,
and regeneration, which has been attributed to the release of paracrine signals by endothelial
cells. Endothelial tubules are associated with specialised mesenchymal cells, termed peri-
cytes, which help to maintain vessel wall integrity. Here we identify pericytes as regulators of
epithelial and endothelial morphogenesis in postnatal lung. Mice lacking expression of the
Hippo pathway components YAP and TAZ in pericytes show defective alveologenesis.
Mutant pericytes are present in normal numbers but display strongly reduced expression of
hepatocyte growth factor leading to impaired activation of the c-Met receptor, which is
expressed by alveolar epithelial cells. YAP and TAZ are also required for expression of
angiopoietin-1 by pulmonary pericytes, which also controls hepatocyte growth factor
expression and thereby alveologenesis in an autocrine fashion. These ﬁndings establish that
pericytes have important, organ-speciﬁc signalling properties and coordinate the behavior of
epithelial and vascular cells during lung morphogenesis.
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B lood vessels form an extensive network of highly branchedendothelial tubules that are covered by specialized sup-porting cells, pericytes, and vascular smooth muscle cells,
surrounded by an extensive amount of extracellular matrix.
Pericytes and capillary endothelial cells (ECs) contact each other
and share the vascular basement membrane1. In addition to the
delivery of circulating cells, oxygen and nutrients, blood vessels
also provide instructive signals controlling organogenesis,
homeostasis, and regeneration2–4. The pulmonary vasculature has
characteristic physiology and functionality, which centers around
a complex alveolar gas exchange unit composed of a thin alveolar
epithelium and a closely associated capillary plexus5,6. Previous
work has established that proper growth and function of the
vascular endothelium is indispensable for lung development,
homeostasis, and regeneration2,7–9. By contrast, pulmonary
pericytes have been mostly implicated in lung ﬁbrosis10,11 and
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pulmonary hypertension12, whereas their physiological function
remains largely uncharacterized.
Alveologenesis, which is mainly a postnatal event between
postnatal day (P) 5 and 30 in mice achieved through secondary
septation subdividing the alveolar sac, is a highly integrated
process that involves cooperative interactions between alveolar
type 1 (AT1) and type 2 (AT2) epithelial cells, ECs, and a number
of different mesenchymal cell types5,6. The disruption of this
coordinated process has been implicated in neonatal diseases such
as bronchopulmonary dysplasia (BPD).
Hippo signalling is a potent regulator of development, differ-
entiation, and tissue homeostasis. The transcriptional co-activator
Yes-associated protein 1 (Yap1) and WW domain containing
transcription regulator 1 (WWTR1 or Taz), which binds to TEA
domain (TEAD) proteins to form an active transcriptional
complex controlling gene expression, are crucial for these func-
tions. Yap1/Taz are phosphorylated by the complex of large
tumor suppressor homolog 1/2 (Lats1/2) kinase and MOB kinase
activator 1 (MOB1), which are activated by serine/threonine
kinase 3 (Stk3/Mst2) and 4 (Stk4/Mst1) and the Salvador Family
WW Domain Containing Protein 1 (Sav1) complex, leading to
the inactivation of Yap1/Taz through exclusion from the cell
nucleus and the promotion of proteolytic degradation13. Global
genetic deletion of Wwtr1 results in development of multiple
renal cysts and pulmonary emphysematous changes14. In addi-
tion, the alternation of Hippo pathway components in epithelial
cell lineage results in impaired lung development15,16.
Here, we have investigated the function of pulmonary pericytes
in the postnatal lung vasculature using inducible genetic experi-
ments in mice in combination with three-dimensional imaging of
thick sections at high resolution. We have made use of Pdgfrb
(BAC)-CreERT2 transgenic mice, which allow tamoxifen-
inducible Cre-mediated recombination speciﬁcally in PDGFRβ-
expressing cells. Pdgfrb(BAC)-CreERT2-mediated inactivation of
the murine Yap1 and Wwtr1 genes led to impaired alveolar
development by differentially altering the hepatocyte growth
factor (HGF)/c-Met signalling pathway in epithelial cells, and
angiopoietin-1/Tie2 signalling in ECs. Accordingly, the inactiva-
tion of the gene encoding angiopoietin-1 in PDGFRβ+ cells also
impaired postnatal alveologenesis. Our ﬁndings demonstrate that
pericytes have crucial, tissue-speciﬁc properties and help to
orchestrate organ morphogenesis.
Results
Characterisation of pulmonary pericytes during lung devel-
opment. To study alveolar development and the role of pericytes
in this process, we performed immunostaining and imaging of
thick lung sections (200–300 µm). Combined RAGE and
PECAM1 staining, which labels AT1 cells lining the inner surface
of the lung and parenchymal ECs, respectively, showed that small
epithelial saccules have formed at postnatal day (P) 4 (Supple-
mentary Fig. 1a–c). At P21, the size of terminal airspaces is
transiently decreased during alveolarization, which is followed by
their expansion by P50 reﬂecting the growth of lung par-
enchyma17 (Supplementary Fig. 1a, c). Coordinated development
of a densely interconnected and ﬂat capillary plexus can be also
observed, which is highly distinct in its morphology from vessels
in other organs18 (Supplementary Fig. 1b, c; Supplementary
Movie 1). Three-dimensional high-resolution images reveal the
presence of pericytes, identiﬁed by expression of platelet-derived
growth factor receptor β (PDGFRβ), in close association with
capillaries but also with AT1 and AT2 epithelial cells in 4-week-
old lungs (Fig. 1a–d and Supplementary Fig. 1d, Supplementary
Movie 2). Quantitative analysis of ECs, visualized by expression
of membrane-anchored tdTomato ﬂuorescent protein and
nuclear H2B-green ﬂuorescent protein (GFP) fusion protein in
Cdh5-mT/nG transgenic mice, and PDGFRβ+ pericytes at dif-
ferent developmental stages indicate a relatively stable ratio of
ECs to pericytes of 7:1 to 9:1 (Fig. 1e and Supplementary Fig. 1e,
f). Making use of PDGFRβ (encoded by the Pdgfrb gene) as a
pericyte marker, we visualized the morphology and localization of
these cells after irreversible genetic labelling with Pdgfrb(BAC)-
CreERT2 transgenic mice19. Following administration of tamox-
ifen from P1 to P3, Pdgfrb(BAC)-CreERT2-induced expression of
GFP under control of the R26-mT/mG Cre reporter labels
PDGFRβ+ pericytes in tight association with PECAM1+ ECs at
P7, P21, and P50 (Fig. 1f–h and Supplementary Fig. 1g–i). Lim-
iting the number of Cre recombination events by single admin-
istration of a low dose of 4-hydroxytamoxifen (4-OHT) enables
the visualization of morphological changes in GFP+ pericytes,
which extend numerous short cellular protrusions by P7 but
display fewer, thinner, and longer processes at later stages (Sup-
plementary Fig. 1h). Further characterization of Pdgfrb(BAC)-
CreERT2 R26-mT/mG double transgenic mice conﬁrmed that
tamoxifen administration at P1–P3 did not lead to GFP expres-
sion in PDGFRα+ ﬁbroblasts and alpha smooth muscle actin
(αSMA)+ bronchial smooth muscle cells or myoﬁbroblasts
(Fig. 1i–k and Supplementary Fig. 2a–c). Quantitative reverse
transcription PCR (RT-qPCR) analysis shows a strong enrich-
ment of transcripts characteristic for pericytes, namely Pdgfrb,
Cspg4, and Notch3, in GFP+ cells isolated from Pdgfrb(BAC)-
CreERT2 R26-mT/mG lungs (Fig. 1l; Supplementary Fig. 2d and
3a, b). By contrast, expression of transcripts for Pecam1
(encoding an endothelial junction protein) and Sftpc (the mRNA
for surfactant protein C) is very low arguing against Pdgfrb(BAC)-
CreERT2-mediated recombination in ECs or epithelial cells
(Fig. 1l and Supplementary Fig. 3a). Coexpression of NG2 and
Fig. 1 Characterisation of pulmonary pericytes during alveologenesis. a, b Three-dimensional reconstruction (a) and high magniﬁcation thin optical section
(b) of confocal images with Airyscan detection showing AQP5-stained type 1 alveolar epithelial cells (green), PDGFRβ-stained pulmonary pericytes (PCs)
(red) and PECAM1-stained endothelial cells (ECs) (blue) in lung at 4 weeks. Panels on the right show higher magniﬁcation of corresponding insets (a) or
single channels (b). Scale bar, 30 µm (a, left), 15 µm (a, right), 10 µm (b, left) and 5 µm (b, right panels). c, d Three-dimensional reconstruction (c) and thin
optical section (d) of confocal images showing SFTPC-stained, cuboidal AT2 cells (green), PDGFRβ-stained PCs (red) and RAGE-stained AT1 cells (blue) in
lung at 4 weeks. Panels on the right show higher magniﬁcation of corresponding insets. Scale bar, 20 µm (left), 10 µm (right). e Quantitation of EC to PC
ratio as measured in peripheral lung sections at different developmental stages. Data represents mean ± s.e.m. (n= 5 for P7, n= 6 for P21 and Adult mice).
f Scheme showing the time points of tamoxifen administration (P1–3) and analysis for the Pdgfrb(BAC)-CreERT2 R26-mT/mG mice. g–k High magniﬁcation
images of Pdgfrb(BAC)-CreERT2 R26-mT/mG lung sections at indicated stages showing pulmonary GFP+ PCs (green), PECAM1+ ECs, PDGFRβ+ PCs,
PDGFRα+ ﬁbroblasts or αSMA+ bronchial smooth muscle cells/myoﬁbroblasts (red, as indicated). Arrows in g indicate PC cell bodies, in g–k GFP-positive
PDGFRβ+ cells (g, h), GFP-negative PDGFRα+ cells (i) or αSMA+ cells (j, k) are marked. Scale bar, 20 µm (g, h), 15 µm (i, k) and 30 µm (j). l RT-qPCR
analysis of Pdgfrb (pericytes), Pecam1 (endothelium), and Sftpc (epithelium) expression in freshly sorted GFP+, CD31+ or EpCAM+ cells from P7 Pdgfrb
(BAC)-CreERT2 R26-mT/mG lung. Data represents mean ± s.e.m. (n= 4 mice)
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Notch3 in pulmonary pericytes is also conﬁrmed by immunos-
taining in Pdgfrb-CreERT2 R26-mT/mG and Cspg4-dsRed.T1
reporter mice (Supplementary Fig. 3c, d). Therefore pulmonary
pericytes dynamically change their morphology in the course of
lung development and these cells can be genetically modiﬁed and
tracked with Pdgfrb-CreERT2 transgenic mice.
Defective alveologenesis in pericyte-speciﬁc Yap1,Wwtr1
knockout mice. The Hippo signalling pathway is a potent reg-
ulator of cell growth, differentiation, and tissue homeostasis, and
has been implicated in the development of the pulmonary epi-
thelium and tumourigenesis13,14. Two core components of the
Hippo pathway, the transcriptional coregulators YAP1 and TAZ,
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are expressed by pulmonary pericytes (Supplementary Fig. 4a, c).
To analyse the function of YAP1 and TAZ in pulmonary peri-
cytes, Pdgfrb(BAC)-CreERT2 mice were interbred with mice
carrying loxP-ﬂanked alleles of Yap1 or Wwtr1. The resulting
Yap1iPCKO or Wwtr1iPCKO single mutants do not display a pro-
minent lung phenotype, although YAP1 or TAZ immunostaining
in PDGFRβ+ pericytes is strongly diminished (Supplementary
Fig. 4b, d–f). To exclude the possibility of functional redundancy,
we also generated Yap1,Wwtr1iPCKO double mutants. Western
blot analysis revealed strong reductions in YAP1 and WWTR1
protein levels in P12 Yap1,Wwtr1iPCKO relative to littermate
control total lung lysates despite the expression of both gene
products by multiple cell types (Supplementary Fig. 4g). Yap1,
Wwtr1iPCKO double mutant lungs display impaired alveolariza-
tion and a severe emphysema-like morphology (Fig. 2a and
Supplementary Fig. 4h, i). A marked increase in airspace volume
and a signiﬁcant reduction of lung volume is already seen in
mutants at P7, while mutant body weight is only slightly
decreased. The weight difference between mutants and littermate
controls increases gradually during postnatal growth leading to a
substantial difference at P18 (Fig. 2b, c and Supplementary
Fig. 5a). However, Yap1,Wwtr1iPCKO double mutants show no
obvious change in vital functions such as arterial oxygen
saturation and respiratory rates (Supplementary Fig. 5b).
Reﬂecting the reduced Yap1,Wwtr1iPCKO lung volumes, we
observed an accumulation of CD31+ ECs and EpCAM+ epi-
thelial cells in G1 phase with a corresponding decrease in
the percentage of cells in S phase, indicative of reduced cell
proliferation (Fig. 2d, e and Supplementary Fig. 5c). Likewise,
there is a notable decrease in AT2 cell proliferation, as
measured by combined SFTPC and EdU staining (Fig. 2f). By
contrast, activated caspase 3 staining, reﬂecting apoptosis, is not
enhanced in Yap1,Wwtr1iPCKO lungs (Supplementary Fig. 5d).
Recent studies have reported that AT2 cells continue to pro-
liferate during postnatal alveologenesis and also include a popu-
lation of stem cells that slowly generate new alveolar cells
throughout adult life20,21, while AT1 proliferation ends within the
ﬁrst week after birth. Immunostaining analysis with NKX2.1, a
lung lineage transcription factor expressed by both AT1 and AT2
cells, and LAMP3 (an AT2 cell marker) shows that the proportion
of AT2 cells is already slightly decreased in P7 Yap1,Wwtr1iPCKO
lungs compared to controls, and this difference is notably exa-
cerbated in P12 lungs (Fig. 3a, b). Yap1,Wwtr1iPCKO pericytes at
P12, labelled by GFP expression from a R26-mT/mG reporter
allele, exhibit narrow and thin processes similar to those seen in
more mature wild-type pulmonary pericytes (Fig. 3c and Sup-
plementary Fig. 1h). Flow cytometry analysis of Yap1,
Wwtr1iPCKO PDGFRβ+ cells shows no signiﬁcant change in
abundance relative to control littermates (Fig. 3d and Supple-
mentary Fig. 5e). Furthermore, immunostaining of PECAM1,
ICAM2, and Erg in P12 Yap1,Wwtr1iPCKO lungs indicates
decreased capillary formation in secondary septa and a reduction
of the pulmonary vasculature (Fig. 3e–h; Supplementary
Movies 3, 4).
It is known that the differentiation of myoﬁbroblasts and their
production of elastin are important for the proper formation of
secondary septa22. Immunostaining of the myoﬁbroblast markers
αSMA and tropoelastin, however, shows no signiﬁcant changes
between control and Yap1,Wwtr1iPCKO lungs (Fig. 3i, j), which is
conﬁrmed by immunoblotting of P7 total lung lysates (Fig. 3k).
Consistent with the absence of Pdgfrb(BAC)-CreERT2 activity in
αSMA+ myoﬁbroblasts in lung, these data argue that impaired
alveologenesis in Yap1,Wwtr1iPCKO mutants is not caused by
myoﬁbroblast defects.
Gene expression changes in YAP1/TAZ-deﬁcient pulmonary
pericytes. To gain more insight into the molecular alterations in
Yap1,Wwtr1iPCKO pericytes, we introduced an Rpl22HA allele,
which enables the immunoprecipitation of actively translating
polyribosome-bound mRNA from Cre-recombined cells23. RNA
isolated and sequenced from control and mutant lungs in tripli-
cate with this approach showed a strong enrichment of pericyte
markers relative to input, whereas transcripts encoding endo-
thelial and epithelial markers were depleted (Supplementary
Fig. 6a). Differential gene expression analysis with an FDR-
adjusted p-value < 0.01 and an absolute log2 fold change > 0.5
identiﬁes 1309 differentially expressed genes, of which 829 are
upregulated and 480 downregulated (Fig. 4a). DAVID Functional
Annotation gene ontology analysis indicates that YAP1/TAZ-
dependent gene changes are associated with cell migration, cell
surface receptor signalling, and vascular development (Fig. 4b).
To investigate how pericytes might control alveolarization, we
focused on potential paracrine regulators. Loss of YAP1 and TAZ
in PDGFRβ+ pericytes reduces the expression of several growth
factors in these cells, including Angpt1, Tgfb2, Wnt11, Bmp4, and
Hgf (Fig. 4c and Supplementary Fig. 6b), many of which have
been previously implicated with high conﬁdence in BPD24. An
analysis of pericytes from different organs indicates that the
growth factor expression proﬁles of these cells are tissue-speciﬁc
and are therefore likely to reﬂect specialized functional roles
(Fig. 4d).
Alteration of HGF/c-Met signalling pathway in YAP1/TAZ-
deﬁcient pulmonary pericytes. First, we investigated the HGF
signalling pathway, as it is known that signalling by HGF and its
receptor c-Met is important for lung morphogenesis25,26. At P7,
Hgf expression predominates in pulmonary pericytes, while Met
transcripts are expressed in epithelial cells (Fig. 4e). Character-
ization of c-Met immunostaining indicates that the receptor is
mainly expressed by SFTPC+ cells in P12 lungs (Fig. 4f and
Supplementary Fig. 6c). In Yap1,Wwtr1iPCKO mutants, expres-
sion of Hgf in pericytes is reduced and levels of phosphorylated
c-Met, but not of total c-Met, are substantially lower in total lung
Fig. 2 Altered alveologenesis in PC-speciﬁc Yap1 and Wwtr1 mutant mice. a Three-dimensional reconstruction confocal images of Yap1,Wwtr1iPCKO and
littermate control lungs stained for AQP5 (green), PDGFRβ (red), and PECAM1 (blue) at the indicated stages. Scale bar, 50 µm. b Quantitation of airspace
volume in Yap1,Wwtr1iPCKO and control lung sections with three-dimensional reconstruction surface images. Data represents mean ± s.e.m. (n= 4 mice;
unpaired two tailed student t-test or Welch’s t-test) c Lung volume measurement of Yap1,Wwtr1iPCKO and littermate control lungs at the indicated stages.
Data represents mean ± s.e.m. (n= 5 for P7, n= 7 for P12, n= 7 for P18 controls, n= 5 for P18 mutant mice, two-tailed unpaired t-test). d Representative
ﬂow cytometry plots of EdU incorporation in EpCAM+ cells from P7 Yap1,Wwtr1iPCKO and littermate control mice. e Diagrams showing ﬂow cytometry cell
cycle analysis of CD31+ or EpCAM+ cells in P7 Yap1,Wwtr1iPCKO and littermate control lungs. Data represents mean ± s.e.m. (n= 8 mice, NS: not
signiﬁcant, Unpaired two tailed student t-test or Welch’s t-test). f Three-dimensional reconstruction confocal images of P7 Yap1,Wwtr1iPCKO and littermate
control lungs stained for SFTPC (green), EdU (red), and DAPI (blue). Quantitation of EdU positive and SFTPC positive cells is shown on the right. Data
represents mean ± s.e.m. (n= 4; unpaired two tailed student t-test). Scale bar, 30 µm
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lysates (Fig. 4g, h). Treatment of cultured pericytes with Verte-
porﬁn, which inhibits YAP1/TAZ function by preventing nuclear
translocation27, suppresses the expression of Hgf in pericytes
in vitro in a dose-dependent fashion without cell toxicity (Fig. 4i
and Supplementary Fig. 6d, e). Likewise, HGF release by pericytes
into the culture medium is also strongly reduced (Fig. 4i), which
established that HGF production by pericytes is perfusion-
independent.
Pericyte-derived Angpt1 regulates alveologenesis. In addition to
HGF/c-Met signalling, angiopoietin-1 (Angpt1), one of the
growth factors that is highly expressed by pulmonary pericytes
(Fig. 4d), and the corresponding receptor Tie2/Tek, which is
expressed by ECs (Fig. 5a), are involved in lung morphogenesis28.
Expression of Angpt1 by PDGFRβ+ pulmonary pericytes is also
conﬁrmed with Angpt1GFP knock-in reporter mice (Fig. 5b).
Whereas levels of Angpt1 are dramatically reduced in Yap1,
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Wwtr1iPCKO PDGFRβ+ cells, as well as in cultured wild-type
pericytes treated with Verteporﬁn or after siRNA-mediated
depletion of Tead1/2/3/4, the expression of other components
of this pathway is not altered in pulmonary ECs (Fig. 5c–e, and
Supplementary Fig. 7a, b). A previously known TEAD binding
motif can be identiﬁed in the upstream sequence of the Angpt1
gene. To test the functionality of this DNA element, a fragment
harbouring the −40 kb TEAD binding site was inserted into a
luciferase reporter. This sequence leads to an increase in luciferase
reporter expression, which is reduced upon mutation of the
TEAD-binding DNA motif (Supplementary Fig. 7c). This result
argues that a YAP/TAZ-TEAD complex transcriptionally reg-
ulates the expression of Angpt1.
Western blot analysis of Yap1,Wwtr1iPCKO lung lysates
conﬁrms strongly decreased expression of Angpt1 protein and
signiﬁcantly lower levels of phosphorylated Tie2 relative to
control samples (Fig. 5f–h). As global Angpt1 knockout mice are
embryonic lethal29, lungs from inducible Pdgfrb(BAC)-CreERT2-
mediated Angpt1 mutants (Angpt1iPCKO) were analysed (Fig. 5i).
Angpt1iPCKO lungs copy major aspects of the Yap1,Wwtr1iPCKO
phenotype such as alveologenesis defects, reduced capillary
formation in the secondary septa and increased airspace volume
(Fig. 5j–l, and Supplementary Fig. 7d). Like Yap1,Wwtr1iPCKO
mutants, Angpt1iPCKO mice show no signiﬁcant differences in
myoﬁbroblasts and tropoelastin deposition (Fig. 5m, n). Inter-
estingly, expression of Hgf is also reduced in Angpt1iPCKO mutant
pericytes (Supplementary Fig. 7e). It was previously shown that
Angpt1 induces HGF expression in cultured endothelial cells and
thereby promotes smooth muscle cell migration30. We found that
treatment of cultured primary lung pericytes with high
concentrations of COMP-Ang1, a soluble and stable variant of
Angpt1, induces the expression of Hgf (Supplementary Fig. 7f).
As transcripts encoding the angiopoietin-1 receptor Tie2
were strongly expressed in CD31+ ECs but not in pericytes
isolated from P7 lung, we explored whether COMP-Ang1
might act through another receptor such as the integrin
αvβ5, which was shown to mediate Angpt1-induced effects
in astrocytes31. Consistent with a role of integrin αvβ5,
treatment with anti-integrin αv blocking antibody completely
suppresses the Angpt1-triggered increase in Hgf expression in
cultured pulmonary pericytes (Supplementary Fig. 7g). Based on
these ﬁndings, we also tested whether treatment with recombi-
nant COMP-Ang1 might restore alveologenesis in Yap1,
Wwtr1iPCKO mice. Remarkably, repeated COMP-Ang1 adminis-
tration at P4, P6, P8, and P10 leads to partially but signiﬁcantly
improved alveologenesis in P12 Yap1,Wwtr1iPCKO mice (Supple-
mentary Fig. 7h, i). The sum of these ﬁndings indicates that
Angpt1 regulates Hgf expression in pericytes cell-autonomously
and thereby plays an important role in postnatal lung
morphogenesis.
Substrate stiffness controls YAP1/TAZ localization. Next, we
investigated the upstream factors controlling YAP1/TAZ activity
in pulmonary pericytes. Mst1/Stk4 and Mst2/Stk3 are part of the
canonical Hippo pathway and negative regulators of YAP1/TAZ
activity13. However, postnatal Pdgfrb(BAC)-CreERT2-mediated
ablation of Stk3 and Stk4 genes does not affect normal lung
morphogenesis (Supplementary Fig. 8a, b). Mechanical properties
of tissues, such as its elasticity or stiffness, are pivotal regulators of
morphogenesis32 and mechanotransduction has been implicated
in the regulation of YAP1/TAZ activity33. Interestingly, several
genes related to tissue microelasticity are upregulated at P21 in
pulmonary pericytes (Supplementary Fig. 8c), suggesting that
local tissue stiffness increases during alveolar morphogenesis.
Consistent with the regulation of lung pericytes by biomechanical
parameters, YAP1/TAZ are mostly cytoplasmic in these cells
when cultured on soft substrates, whereas growth on stiff sub-
strates leads to nuclear accumulation of YAP1/TAZ and the
extension of pericyte protrusions similar to those seen in vivo
(Supplementary Fig. 1h and 8d, e).
Together, our results establish that pericytes act as important
morphogenetic regulators with specialized, presumably organ-
speciﬁc properties. In postnatal lung, the paracrine signalling
capability of pericytes, which is controlled by YAP1/TAZ and
mechanical factors, is crucial for the interplay with AT2 epithelial
cells and thereby alveologenesis (Fig. 5o).
Discussion
The lung is thought to comprise as many as 40 different cell types
including several epithelial cell subpopulations. Squamous AT1
alveolar cells cover most of the internal surface of the pulmonary
tree, whereas cuboidal AT2 cells are conﬁned to the corners of the
alveolus. In addition to their important role in the production,
secretion, and recycling of pulmonary surfactant34, postnatal AT2
cells have stem cell-like roles, can give rise to AT1 cells and
contribute to alveolar renewal, lung repair, and cancer20,21.
During development, both AT1 and AT2 cells arise from a
bipotent progenitor20,35. Other studies have identiﬁed bronch-
ioalveolar stem cells (BASCs) as the source of bronchiolar and
alveolar cells during injury repair and as a potential target in
disease processes9. Multiple pathways, including epithelial growth
factor (EGF), bone morphogenetic protein (BMP), ﬁbroblast
growth factor (FGF), and HGF signalling, have been proposed to
control the properties of pulmonary epithelial stem and pro-
genitor cells. High expression of c-Met has been reported both in
Fig. 3 Lung phenotype of PC-speciﬁc Yap1,Wwtr1 mutants. a Maximum intensity projections of P7 and P12 Yap1,Wwtr1iPCKO and littermate control lungs
showing NKX2.1-stained (green) AT1 and AT2 cell nuclei, LAMP3-stained AT2 cells (red), and DAPI (blue). Scale bar, 30 µm. b Quantitation of NKX2.1
positive and LAMP3 positive cells shown in a. Data represents mean ± s.e.m. (n= 4 mice; two-tailed unpaired t-test or Welch’s t-test). c Three dimensional
high magniﬁcation reconstruction images of Yap1,Wwtr1iPCKO R26-mT/mG and littermate control lungs stained for GFP (white). Scale bar, 20 µm. d Flow
cytometric analysis of PDGFRβ+ pericytes in P12 Yap1,Wwtr1iPCKO and control lungs. Data represents mean ± s.e.m. (n= 7 mice; NS not signiﬁcant, two-
tailed unpaired t-test). e, f Confocal images of P12 Yap1,Wwtr1iPCKO and littermate control lungs stained for PECAM1 (white). Note formation of capillaries
at the secondary septa in controls (arrowheads) but not in mutants. Panels in f show higher magniﬁcation of insets in e. Scale bar, 20 µm (e) and 10 µm (f).
g Three-dimensional high magniﬁcation reconstruction images of P12 Yap1,Wwtr1iPCKO and littermate control lungs stained for ERG (green), ICAM2 (red),
and DAPI (blue). Scale bar, 30 µm. h Quantitation of ICAM2-stained vascular density based on 3D reconstruction surface images, as shown in g. Data
represents mean ± s.e.m. (n= 4 mice; unpaired two tailed student t-test) i Maximum intensity projections of P7 Yap1,Wwtr1iPCKO and littermate control
lungs stained for αSMA (red) and tropoelastin (blue). Scale bar, 100 µm. j Quantitation of staining intensity for αSMA or tropoelastin shown in i. Signal
intensity was normalized to the size of the parenchymal region. Data represents mean ± s.e.m. (n= 4 mice; NS not signiﬁcant, two-tailed unpaired t-test).
k Western blot analysis of αSMA and tropoelastin in P7 Yap1,Wwtr1iPCKO and littermate control total lung lysates (n= 3 mice). Molecular weight marker
(kDa) is indicated
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BASC and primary AT2 cells from rat lung36, which is consistent
with our own data showing prominent c-Met immunostaining of
SFTPC+ cells in P12 lung. HGF/c-Met signalling mediates the
proliferation and branching morphogenesis of lung epithelial cells
in vitro36,37 and, as the administration of neutralizing anti-HGF
antibody or truncated (soluble) c-Met protein show, is also
essential for alveologenesis in neonatal rats38. Mice with an AT2
cell-speciﬁc, postnatal deletion of Met show impaired alveolar
formation and reduced AT2 cells26, which is consistent with our
ﬁndings in Yap1,Wwtr1iPCKO lungs. HGF expression in lung has
been previously attributed to lung mesenchymal cells and
ﬁbroblasts39,40. Our own data now argue that pericytes are a
critical source of HGF in the postnatal lung and, accordingly,
Pdgfrb(BAC)-CreERT2-mediated loss of Yap1 and TAZ drama-
tically reduces HGF expression in PDGFRβ+ cells and thereby
levels of active (phosphorylated) c-Met in total lung lysates. These
data indicate that postnatal pulmonary pericytes are a key source
of growth factor signals controlling the behaviour of epithelial
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progenitor cells, which might be also relevant in the context of
disease processes. It has been reported that low HGF con-
centrations in tracheal aspirate ﬂuid samples of human neonates
are associated with more severe BPD, a common chronic lung
disease affecting premature infants41. Exome-sequencing has also
identiﬁed nonsynonymous mutations in the human HGF gene as
a genetic factor predisposing to BPD24. In addition, treatment
with recombinant HGF improves lung defects in the hyperoxia-
induced neonatal mice model of BPD42. Mice lacking c-Met in
AT2 epithelial cells show an increase in oxidative stress, which is
relevant to chronic obstructive pulmonary disease (COPD)26,43.
Reduced HGF secretion in peripheral lung of COPD patients
correlates with disease severity44. Future work should therefore
consider pulmonary pericytes in the context of pathologically
altered HGF production.
Signalling by angiopoietins and the receptor tyrosine kinase
Tie2 plays important roles in the regulation of angiogenesis, EC
survival, and vascular integrity45,46. While expression of
angiopoietin-1 is frequently attributed to pericytes and mural
cells47,48, we found that this is indeed the case for lung but,
unexpectedly, not for brain and retina at P7. Moreover, pericyte-
derived angiopoietin-1 is indispensable for alveologenesis and is
also likely to control EC behaviour in postnatal lung, which
would help to coordinate multiple different cell types during
pulmonary development. Paracrine (also termed angiocrine)
signalling has been previously associated with ECs in the control
of organ morphogenesis and regeneration2–4,49. Unexpectedly,
pericytes emerge from our study as novel regulators of tissue
growth and patterning in addition to their acknowledged roles in
the maintenance of vessel integrity. We also found that pericytes
express distinct growth factor signatures in an organ-speciﬁc
fashion, which may well reﬂect distinct functional roles in the
regulation of morphogenetic processes in the surrounding
tissue. Thus, pericytes are not only safeguarding vascular integrity
but are also specialized mediators of tissue morphogenesis
with potential relevance for pathobiological processes and
regeneration.
Methods
Mouse models. C57BL/6J mice were used for the analysis of wild-type lung.
Lineage tracing experiments were performed by mating Pdgfrb(BAC)-CreERT219,50
and R26-mT/mG reporter mice51. Cre activity and GFP expression were induced by
intraperitoneal injection of 50 µg tamoxifen (T5648, Sigma) in ethanol/Kolliphor
EL (C5135, Sigma) from postnatal day (P) 1 to 3 or 1 µg 4-hydroxy tamoxifen
(4-OHT) in ethanol/Kolliphor EL (H7904, Sigma) at P2 for a low dosage. For
inducible genetic experiments, Pdgfrb(BAC)-CreERT2 transgenics were interbred
with mice carrying loxP-ﬂanked Yap1 (Yap1lox/lox), Wwtr1 (Wwtr1lox/lox)52,
Angpt1 (Angpt1lox/lox)53, Stk3 (Stk3lox/lox), or Stk4 (Stk4lox/lox) alleles54. Cre activity
and gene inactivation were induced by intraperitoneal injection of 50 µg tamoxifen
from P1 to 3. Tamoxifen was administered to both controls and mutants in all
inducible genetic experiments. At the age of P7, P12, and P18, lungs were collected
from Yap1lox/lox Wwtr1lox/lox Pdgfrb(BAC)-CreERT2T/+ (Yap1,Wwtr1iPCKO)
mutants and Cre-negative Yap1lox/lox Wwtr1lox/lox littermate controls. P12 lungs
were collected from Yap1lox/lox Pdgfrb(BAC)-CreERT2T/+ (Yap1iPCKO), Wwtr1lox/
lox Pdgfrb(BAC)-CreERT2T/+ (Wwtr1iPCKO), Angpt1lox/lox Pdgfrb(BAC)-CreERT2T/
+ (Angpt1iPCKO) or Stk3lox/lox Stk4lox/lox Pdgfrb(BAC)-CreERT2T/+ (Stk3,
Stk4iPCKO) mutants and the corresponding Cre-negative littermate controls. Yap1,
Wwtr1iPCKO mice were also interbred with R26-mT/mG reporters and the resulting
Yap1lox/lox Wwtr1lox/lox Pdgfrb(BAC)-CreERT2T/+ mutants and Yap1lox/+
Wwtr1lox/+ Pdgfrb(BAC)-CreERT2T/+ controls were analysed at P12 after tamox-
ifen administration from P1 to P3. For RiboTag analysis, mice were interbred with
Rpl22tm1.1Psam (Rpl22lox/lox) mice23. Yap1lox/lox Wwtr1lox/lox Rpl22lox/+ Pdgfrb
(BAC)-CreERT2T/+ mutants and Yap1lox/+ Wwtr1lox/+ Rpl22lox/+ Pdgfrb(BAC)-
CreERT2T/+ controls were analysed at P8 after tamoxifen administration from P0
to P2. For RT-qPCR or RNA-seq analysis of RiboTag samples, Rpl22lox/lox Pdgfrb
(BAC)-CreERT2T/+ mice were analysed at P2, P7 or P21 after 50 µg 4-OHT
administration at P1. Tg(Cspg4-DsRed.T1)1Akik55 and Angpt1tm1.1Sjm reporter
mice56 were previously published. Cdh5-mT/nG transgenic mice were generated as
follows: A cDNA encoding membrane-tagged tdTomato (Addgene plasmid #
17787), 2A peptide, AU1 tag and H2B-EGFP (Addgene plasmid # 11680) followed
by a polyadenylation signal sequence and a FRT-ﬂanked ampicillin resistance
cassette were introduced by recombineering into the start codon of Cdh5 in PAC
clone 353-G15. After Flp-mediated excision of the ampicillin resistance cassette in
bacteria, the resulting constructs were validated by PCR analysis and used in
circular form for pronuclear injection into fertilized mouse oocytes. Founders,
identiﬁed by PCR genotyping, were screened by immunostaining with ERG anti-
body. Genotypes of mice were determined by PCR. Arterial oxygen saturation and
respiratory rate were measured with a Collar Sensor by MouseOx Plus (Starr Life
Sciences Corp, USA) as outlined in the manufacturer’s instructions. For the
administration of COMP-Ang157, Yap1,Wwtr1iPCKO and control littermates were
injected with tamoxifen from P1 to P3 and with COMP-Ang1 (12.5 μg) or similar
volume of PBS at P4, P6, P8, and P10, analysed at P12. All animal experiments
were performed in compliance with the relevant laws and institutional guidelines,
were approved by local animal ethics committees and were conducted with per-
missions granted by the Landesamt für Natur, Umwelt und Verbraucherschutz
(LANUV) of North Rhine-Westphalia to the Max Planck Institute for Molecular
Biomedicine or by the Animal Care and Use Committee of KAIST (No. KA2015-
15). Animals were combined in groups for experiments irrespective of their sex.
Lung sample preparation and immunohistochemistry. Mice up to 12 days old
were anesthetized with ketamine/xylazine, before the chest cavity was opened by
cutting along the sternum and the ribs adjacent to the diaphragm to expose the
heart and lungs. A warm (37 °C) solution of 6% gelatin (G1890, Sigma) in PBS was
gently perfused through the right ventricle with manual pressure. Before taking out
the needle from right ventricle, a small, ice-cold cotton pad was placed on the
injected site to solidify the gelatin inside the heart. The ventral trachea was can-
nulated with an intravenous catheter tube. The lungs were inﬂated to full capacity
by gently injecting warm (37 °C) 1% low gelling agarose (A4018, Sigma) in PBS.
After agarose-inﬂation, the lungs were exposed to ice-cold PBS. The lungs and
heart were removed and placed in 2% paraformaldehyde solution (PFA in PBS,
4 °C, P6148, Sigma) for 30 min. Lungs from older mice (13 days or more) were
processed as described except that following anesthesia, trachea was cannulated
with an intravenous catheter tube that was secured by tying a suture around the
trachea. The lungs were inﬂated with air followed by the perfusion of gelatin
solution (~25 mmHg). The inﬂated lungs were deﬂated by releasing positive air
pressure followed by re-inﬂation to total lung capacity with agarose solution
(~20–25 cmH2O). After the exposure to ice-cold PBS to solidify the agarose, the
cannula was withdrawn and the suture tightened.
Fig. 4 Gene expression changes in Yap1,Wwtr1iPCKO pericytes. a MA-plots of differentially regulated genes between P8 Yap1,Wwtr1iPCKO and control
pericytes. The x-axis represents the mean normalized counts and the y-axis shows the log2 fold change. Differentially regulated genes are represented by
red colored points (FDR-adjusted P-value < 0.01 and absolute log2 fold change > 0.5). b Gene ontology analysis for signiﬁcantly differentially regulated
genes (RNA-seq analysis) in Yap1,Wwtr1iPCKO and control pericytes. c RiboTag and RNA-seq-based expression levels of the indicated transcripts relative to
P8 control. RPKM (reads per kilobase of exon per million mapped reads) values obtained from RNA-seq are shown. Data represents mean ± s.e.m. (n= 3).
d RT-qPCR analysis of indicated transcripts in immunoprecipitated (IP) RNA from P7 Pdgfrb(BAC)-CreERT2 Rpl22HA lung, brain, heart, retina, and inguinal
white adipose tissues (WAT). Data represents mean ± s.e.m. (n= 4 mice). e RT-qPCR analysis of Hgf and Met expression in freshly sorted GFP+, CD31+
or EpCAM+ cells from P7 Pdgfrb-CreERT2 R26-mT/mG lungs. Data represents mean ± s.e.m. (n= 4 mice). f High magniﬁcation images of P12 lungs stained
for SFTPC (green), c-Met (red), and RAGE (blue). Arrows indicate SFTPC+ c-Met+ cells. Scale bar, 15 µm. g Hgf expression in freshly sorted PDGFRβ+ or
CD31+ cells from P7 Yap1,Wwtr1iPCKO and littermate control lungs. Data represents mean ± s.e.m. (n= 5 mice; NS not signiﬁcant, Welch’s t-test or two-
tailed unpaired t-test). h Western blot analysis of total and phosphorylated c-Met (pMet) in P12 Yap1,Wwtr1iPCKO and control total lung lysates (n= 2 for
controls and 4 for mutant mice). Molecular weight marker (kDa) is indicated. i RT-qPCR analysis of Hgf mRNA expression (left) and HGF levels in
supernatants (right) from 1 µM Verteporﬁn (VP) treated cultured pericytes and controls at 48 h. Data represents mean ± s.e.m. (n= 4 and 6, Welch’s
t-test). n.d. not detectable
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The lung lobes were separated and trimmed to create a ﬂat surface, glued to a
mounting block with cyanoacrylate glue (UHU, 48700), submerged in ice-cold PBS
and sliced (200–300 µm) using vibrating blade microtome (VT1200, Leica). Lung
slices were ﬁxed in 4%PFA/PBS at 4 °C for 1 h, washed thoroughly in PBS and
incubated twice in PBS at 55 °C for 30 min. After washing in PBS, blocking solution
(5% donkey serum, 0.5% Triton X-100 in PBS) was applied for 30 min at room
temperature and sections were treated with primary antibodies in blocking solution
over night at 4 °C. Following two washes with PBS, sections were incubated with
secondary antibodies in blocking solution over night at 4 °C. After three wash steps
with PBS, sections were mounted using FluoroMount-G (Southern Biotech) under
cover slips sealed with nail polish that were spaced from the slide with tapes.
The following primary antibodies were used: rabbit anti-Aquaporin 5 (178615,
Millipore, 1:200), rat anti-CD140b (14–1402, eBioscience, 1:100), goat anti-CD31
(FAB3628, R&D Systems, 1:200), rabbit anti-Prosurfactant Protein C (AB3786,
Millipore, 1:200), chicken anti-GFP (GFP-1010, aves, 1:1000), rabbit anti-GFP
conjugated to Alexa Fluor (AF) 488 (A21311, Thermo Fisher, 1:200), goat anti-
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PDGFR alpha (AF1062, R&D Systems, 1:200), anti-α-SMA-Cy3 (C6198, Sigma,
1:200), anti-α-SMA eFluor 660 (C6198, Sigma, 1:200), rabbit anti-TTF1 (ab76013,
abcam, 1:200), rat anti-DC-LAMP/CD208 (DDX0192, Dendritics, 1:200), rat anti-
CD102 (553326, BD Biosciences, 1:100), rabbit anti-Tropoelastin (ab21600, abcam,
1:200), goat anti-HGF R/c-MET (AF527, R&D Systems, 1:200), rat anti-RAGE
(MAB1179, R&D Systems, 1:200), rabbit anti-ERG (ab110639, abcam, 1:200), goat
anti-PDGFR beta (AF1042, R&D Systems, 1:200), rabbit anti-NG2 (AB5320,
Millipore, 1:100), goat anti-Notch3 (AF1308, R&D Systems, 1:200), rabbit anti-
YAP (#14074, Cell Signaling, 1:100), rabbit anti-WWTR1 (HPA007415, Sigma,
1:200) and rabbit anti-Cleaved Caspase-3 (#9664, Cell Signaling, 1:100).
The following secondary antibodies were used: donkey anti-rabbit IgG
conjugated to AF488 (A21206, Thermo Fisher, 1:400), donkey anti-chicken IgY
AF488 (703-545-155, Jackson ImmunoResearch, 1:400), donkey anti-rat IgG
AF488 (A21208, Thermo Fisher, 1:400), donkey anti-rat IgG Cy3 (712-165-153,
Jackson ImmunoResearch, 1:400), donkey anti-rabbit IgG AF546 (A10040, Thermo
Fisher, 1:400), donkey anti-rat IgG AF594 (A21209, Thermo Fisher, 1:200), donkey
anti-rabbit IgG AF594 (A21207, Thermo Fisher, 1:200), donkey anti-goat IgG
AF647 (A21447, Thermo Fisher, 1:200) and donkey anti-rabbit IgG AF647
(A31573, Thermo Fisher, 1:200). Nuclei were counterstained with DAPI (D9542,
Sigma, 2 µg/ml). Proliferating cells were labelled in vivo by intraperitoneal injection
of 33.3 µg of EdU (Thermo Fisher) per gram of body weight 90 min before sample
collection. After thorough staining and washing, EdU-positive cells were stained
with Click-iT EdU Alexa Fluor 647 Imaging Kit (C10340, Thermo Fisher)
following manufacturer’s instructions. Dissection, processing, sectioning, staining,
imaging, and analysis for phenotypes of mutant mice and controls were always
performed together under identical conditions.
The total lung volume was measured by the ﬂuid displacement method58.
Image acquisition and quantitative analysis. Images of lung sections were
acquired using a Leica TCS SP8 confocal laser scanning microscope with LAS X
software, a Zeiss LSM780/LSM880 confocal laser scanning microscope with online
ﬁngerprinting mode and ZEN software, or a Zeiss LSM880 with Airyscan detector.
Z-stacks of images were processed and 3D reconstructed with Imaris software
(version 7.7.2, Bitplane). Quantitation was performed with Imaris software or
Volocity (Version 6.3, Perkin Elmer). Photoshop and Illustrator (version CS6,
Adobe) were used for image processing. To determine the EC to pericyte ratio, the
number of ECs and pericytes was calculated with Volocity software out of 45 to 54
ﬁelds sized 213 × 213 × 21 µm in ﬁve to six Cdh5-mT/nG transgenic lung samples
per group. ECs were identiﬁed based on nuclear H2B-GFP and tdTomato signals,
and pericytes were identiﬁed as PDGFRβ+ αSMA− and GFP−. The number of
EdU and SFTPC positive cells was measured with Volocity software out of 24 ﬁelds
sized 247 × 247 × 10 µm in four lung samples per group. The number of NKX2.1
and LAMP3 positive cells was measured with Imaris software out of 24 ﬁelds sized
213 × 213 × 20 µm in four lung samples per group. Vessel density was measured
with Imaris out of 20 ﬁelds sized 213 × 213 × 21 µm in four lung samples per group
based on 3D surface rendering images from 3D reconstructed images. Intensity of
αSMA and tropoelastin staining that was normalized based on parenchymal region
was measured with the Volocity out of 20 ﬁelds sized 213 × 213 × 17.7 µm in four
lung samples per group and normalized to the lung parenchymal region. Airspace
volume was measured with Imaris out of 20 or 24 ﬁelds sized 213 × 213 × 31 µm in
four lung samples per group based on 3D surface rendering images from 3D
reconstructed images. The number of active caspase 3 positive cells and total cells
was measured with Imaris software out of 24 ﬁelds sized 213 × 213 × 30 µm in four
lung samples per group. Fields containing major airway or vessel structures were
not included in quantitation. All images shown are representative for the respective
staining in several experiments. Within each experiment, laser excitation and
confocal scanner detection were kept the same.
Flow cytometry. Mice were anesthetized, the chest cavity was opened, and ice-cold
PBS was perfused through the right ventricle and the ventral trachea was cannu-
lated. The lungs were inﬂated by injecting dispase solution (25 U/ml in PBS,
17105041, Thermo Fisher), removed, and other tissues and bronchi were trimmed.
Lungs were minced in 3–5 ml of digestion buffer consisting of Liberase TM (100
µg/ml, 05401119001, Roche) and DNase I (0.1 mg/ml, DN25, Sigma) in MEM
(31095-029, Gibco) supplemented with 25 mM HEPES and incubated with tri-
turation for 30 min at 37 °C. An equal volume of PBS supplemented with 2% FCS
was added and the cell suspension was passed through a 100 µm mesh ﬁlter fol-
lowed by centrifugation at 330 g for 5 min. The precipitated cells were resuspended
in red blood cell lysing buffer (R7757, Sigma), incubated for 4 min, passed through
a 40 µm mesh ﬁlter, centrifuged at 330 g for 5 min, and ﬁnally resuspended in
sorting buffer (PBS supplemented with 2% FCS). For cell sorting from Pdgfrb
(BAC)-CreERT2 R26-mT/mG mice, the cells were immunostained with rat anti-
TER-119-Paciﬁc Blue (116232, BioLegend, 1:100), rat anti-CD45-Paciﬁc Blue
(103126, BioLegend, 1:100), rat anti-CD31-PerCP/Cy5.5 (102420, BioLegend,
1:50), rat anti-CD326-phycoerythrin (PE)/Cy7 (118216, BioLegend, 1:50) and rat
anti-CD140a-allophycocyanin (APC) (17-1401-81, eBioscience, 1:100) for 30 min
on ice. For cell sorting from Yap1,Wwtr1iPCKO mice and Angpt1iPCKO mice, cells
were immunostained with rat anti-TER-119-Paciﬁc Blue (116232, BioLegend,
1:100), rat anti-CD45-Paciﬁc Blue (103126, BioLegend, 1:100), rat anti-CD31-FITC
(RM5201, Thermo Fisher, 1:50), rat anti-CD140a-PE (12–1401–81, eBioscience,
1:100), rat anti-CD326-PE/Cy7 (1:50), rat anti-CD140b-APC (17–1402–82,
eBioscience, 1:25) for 30 min on ice. After washing, cells were treated with DAPI to
exclude dead cells. Cell sorting was performed with a FACS Aria IIu (BD Bios-
ciences) using a 70 µm nozzle and FACSDiva software.
Proliferating cells were labelled in vivo by intraperitoneal injection of 33.3 µg of
EdU (Thermo Fisher) per gram of body weight 90 min before sample collection.
Cell suspensions were prepared as described above and were immunostained with
rat anti-CD31-Biotin (553371, BD Biosciences, 1:100), rat anti-CD140a-PE (1:100),
rat anti-CD326-PE/Cy7 (1:50) and rat anti-CD140b-APC (1:25) for 30 min on ice.
After washing, cells were stained with Streptavidin-BV605 (563260, BD
Biosciences, 1:200) for 30 min on ice. After thorough washing, cells were stained
with Click-iT Plus EdU Alexa Fluor 488 Flow Cytometry Kit (C10632, Thermo
Fisher) following manufacturer’s instructions. Finally, cells were again washed,
treated with DAPI and acquired on FACS Aria IIu, followed by the analysis with
the FlowJo software (FlowJo, LLC). Boundaries between positive and negative
populations have been deﬁned by using single stained and FMO (ﬂuorescence
minus one) controls.
Cell culture and Luciferase assay and ELISA assays. For pulmonary pericyte
culture, freshly sorted CD140β+, CD140α−, CD326−, CD31−, TER-119−, and
CD45− populations were cultured on 100 µg/ml collagen I (BD Biosciences) coated
dishes in Pericyte Medium (#1201, ScienCell). Cultured cells were maintained at
37 °C in a humidiﬁed 5% CO2 atmosphere. More than 80% of cells are PDGFRβ+
and NG2+. Pericytes were transfected with siRNA by using Lipofectamine
RNAiMAX Transfection Reagent (Thermo Fisher) according to the manufacturer’s
instructions. The following Silencer Select siRNAs were purchased from Thermo
Fisher: mouse Tead1 s74929, mouse Tead2 s74931, mouse Tead3 s74934, and
mouse Tead4 s74938. Silencer Select Negative Control No.1 siRNA (Thermo
Fisher) was used for control transfection. Cells were harvested 72 h after trans-
fection. For COMP-Ang1 treatment, cells were serum starved overnight before
stimulation with bovine serum albumin (BSA; 1000 ng/ml) or 100, 500 or 1000 ng/
ml COMP-Ang1 for 24 h in the presence or absence of rat IgG or
anti-Integrin Alpha V antibody (LS-C57970, LifeSpan BioSciences, 30 µg/ml), and
harvested for RNA isolation. For Luciferase assay, we have searched for the known
consensus motif for TEAD mouse genomic sequence up to 50 kbp from
Fig. 5 Pericyte-derived Angpt1 controls alveologenesis. a RT-qPCR analysis of Angpt1 and Tie2/Tek expression in freshly sorted lung GFP+, CD31+ or
EpCAM+ cells from P7 Pdgfrb(BAC)-CreERT2 R26-mT/mGmice. Data represents mean ± s.e.m. (n= 4 mice). b High magniﬁcation images of P10 Angpt1GFP
lungs stained for GFP (green), PDGFRβ (red), and PDGFRα (blue). Arrows indicate GFP and PDGFRβ double positive pericytes. Scale bar, 15 µm. c RT-qPCR
analysis of Angpt1 expression in freshly sorted PDGFRβ+ cells from P7 Yap1,Wwtr1iPCKO and control lungs. Data represents mean ± s.e.m. (n= 4 mice, two-
tailed unpaired t-test). d Angpt1 expression in cultured Verteporﬁn (VP)-treated (48 h) and control pericytes. Data represents mean ± s.e.m. (n= 4,
Welch’s t-test). e Expression of the indicated transcripts in freshly sorted CD31+ cells from P7 Yap1,Wwtr1iPCKO and control lungs. Data represents mean ±
s.e.m. (n= 4 mice, NS not signiﬁcant, two-tailed unpaired t-test). f–hWestern blot analysis of Angpt1 protein (f; n= 2 controls and 4 mutant mice) and of
total and phospho-Tie2 (pTie2) in P12 Yap1,Wwtr1iPCKO and control total lung lysates (g, n= 3 controls and 5 mutants). Molecular weight marker (kDa) is
indicated. Relative quantiﬁcation of signals is shown in h. Two-tailed unpaired t-test. i Scheme showing the time points of tamoxifen administration and
analysis for Angpt1 iPCKO mice. j, k 3D reconstruction confocal images of P12 Angpt1iPCKO and littermate control lungs stained for AQP5 (green), PDGFRβ
(red), and PECAM1 (blue). Panels in k show higher magniﬁcation of PECAM1 staining. Scale bar, 50 µm (j) and 30 µm (k). l Quantitation of airspace
volume in P12 Angpt1iPCKO and littermate control lung sections with 3D reconstruction surface images. Data represents mean ± s.e.m. (n= 4 mice; p <
0.0001, two-tailed unpaired t-test). m 3D reconstruction confocal images of P12 Angpt1iPCKO and littermate control lungs stained for αSMA (red) and
tropoelastin (blue). Scale bar, 50 µm. n Quantitation of staining intensity for αSMA or tropoelastin shown in m. Intensity was normalized to the size of the
parenchymal region. Data represents mean ± s.e.m. (n= 4 mice; NS not signiﬁcant, two-tailed unpaired t-test). o Schematic summary of ﬁndings.
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transcription start site of Angpt1 gene. DNA fragments encompassing approxi-
mately 500 bp of candidate binding regions carrying BamHI and SalI restriction
sites were cloned into pGL4 vector downstream of the Luciferase gene with ubi-
quitin minimal promoter. Mutations in TEAD motif were introduced by site-
directed mutagenesis. Cells were co-transfected with the respective reporter con-
structs and pGL4.75[hRluc/CMV] vector by using Lipofectamine 3000 reagent
(Thermo Fisher). Fireﬂy and Renilla luminescence signals were measured 24 h after
transfection using Dual-Luciferase reporter assay system (E1910, Promega). Fireﬂy
luminescence signals were normalized according to their corresponding Renilla
signals resulting in relative luciferase activity. For Verteporﬁn treatment, pericytes
were treated with 0.1, 0.5 or 1 µM Verteporﬁn (5305, TOCRIS) or DMSO as a
vehicle under the protection from light. After 48 h, supernatants were collected for
measuring HGF concentration using a quantitative enzyme-linked immunosorbent
assay (ELISA) kit (SEA047Mu, Cloud-Clone Corp.). For gene expression analysis,
cells were harvested and processed for RNA isolation as described in the “quan-
titative RT-PCR analysis” section of Methods. For the evaluation of cell toxicity,
Annexin V Apoptosis Detection Kit FITC (88-8005-72, Thermo Fisher) and DAPI
staining was used following the manufacturer’s instructions. After staining, cells
were acquired on FACS Aria IIu, followed by the analysis with the FlowJo software.
The fractions of Annexin V+ and DAPI−, Annexin V+ and DAPI+ and Annexin
V− and DAPI+ were combined as apoptotic cells.
Generation of polyacrylamide hydrogels and immunoﬂuorescence. Poly-
acrylamide hydrogels were prepared according to a previously described protocol59.
Solutions with varying concentrations of acrylamide (1610140, Bio-Rad)/bis-
acrylamide (1610143, Bio-Rad) (3%/0.06 and 8%/0.264%) were mixed to yield
hydrogels of different stiffnesses (0.48 and 19.66 kPa, respectively). To allow for cell
attachment, ﬁbronectin (356009, Corning) was conjugated to the hydrogel surface
using the heterobifunctional linker sulfo-SANPAH. A 1mg/mL solution of sulfo-
SANPAH (803332, Sigma) in milli-Q water was added to the hydrogel surface, and
gels were irradiated with 365 nm UV light (intensity of 20 mW/cm2) for 2 min.
Substrates were washed with PBS and incubated with a 10 μg/mL ﬁbronectin
solution in PBS for 2 h at 37 °C. Samples were washed with PBS prior to cell
seeding. Pericytes were plated in growth medium and harvested after 24 h. Cells
were ﬁxed with 4%PFA/PBS for 10 min at RT followed by permeabilization with
0.2% Triton X-100 for 10 min at RT. After washing with PBS, the cells were
blocked with 1% BSA (A4378, Sigma) for 30 min at RT and incubated with mouse
anti-YAP1/TAZ antibody (sc-101199, Santa Cruz, 1:100) in blocking solution over
night at 4 °C. After washing with PBS, cells were incubated with donkey anti-mouse
IgG AF488 (A21202, Thermo Fisher, 1:200) and AF546 Phalloidin (A22283,
Thermo Fisher, 1:100), followed by nuclear counterstaining with DAPI. Z-stacks of
confocal images were recorded by LSM880. For quantiﬁcation of YAP1/TAZ
subcellular localization, the middle single optical plane was chosen from Z-stacks of
images. The average ﬂuorescence intensity within the region of interest in the
nucleus and outside the nucleus (cytoplasm) was measured to determine the
nuclear/cytoplasmic ratio. Nuclear/cytoplasmic ratio > 1 was deﬁned as nuclear
localization, and nuclear/cytoplasmic ratio < 1 as cytoplasmic localization. A
minimum of 50 cells per replicate were examined for each experimental condition.
RiboTag analysis and RNA sequencing and data analysis. Immunoprecipitation
and puriﬁcation of ribosome-associated RNA was performed as described
previously23,60 with modiﬁcations. Brieﬂy, mouse lungs, brains, hearts, retinas, and
inguinal white adipose tissues were perfused through the right ventricle with cold
HBSS containing 100 µg/ml cyclohexamide (01810, Sigma) and dissected before
snap freezing in liquid nitrogen. Tissues were homogenized in polysome buffer (50
mM Tris-HCl pH 7.4, 100 mM KCl, 12 mMMgCl2, cOmplete ULTRA (Roche), 1%
NP-40, 1 mM DTT, 1000 U/ml RNase inhibitor (M0314, New England BioLabs),
200 U/ml SUPERasein (AM2696, Thermo Fisher), 100 µg/ml cyclohexamide, 1 mg/
ml heparin) with Pestle (ARgos) and clariﬁed by centrifugation at 20,000 × g for 10
min at 4 °C. Before immunoprecipitation, 5% of supernatants were kept as input
and the remaining supernatants were mixed with anti-HA-tag Magnetic Beads
(M180-11, MBL) and rotated for 8 h at 4 °C. Magnetic beads were washed three
times for 5 min in high salt buffer (50 mM Tris-HCl pH 7.4, 300 mM KCl, 12 mM
MgCl2, 1% NP-40, 1 mM DTT, 100 µg/ml cyclohexamide). QIAGEN RLT plus
buffer was added to magnetic beads and total RNA was isolated using the RNeasy
Plus Micro Kit (QIAGEN) according to the manufacturer’s instructions. RNA
quality was assessed using a 2100 BioAnalyzer (Agilent). Hundred nanogram of
RNA were used for preparation of sequencing libraries with the TruSeq Stranded
Total RNA Library Prep Kit (Illumina) according to the manufacturer’s instruc-
tions. Libraries were validated with the BioAnalyzer and quantiﬁed by qPCR and
Qubit Fluorometric Quantitation (Thermo Fisher). The NextSeq 500/550 High
Output v2 Kit or MiSeq Reagent Kit v3 (Illumina) was used for sequencing with a
NextSeq 500 or MiSeq (Illumina) to generate 75-bp pair-end reads. Experiments
were performed in triplicate.
RNA-seq data analysis was performed as described previously61 with some
modiﬁcations. The quality assessment of raw sequence data was performed using
FastQC (Version: FastQC 0.11.3). Paired-end sequence reads were mapped to the
mm10 mouse genome assembly (GRCm38) using TopHat-2 (Version: tophat-
2.0.13)62. The mouse genome was downloaded from the iGenome portal. HTSeq
was used to count the aligned reads on a per gene basis (Version: HTSeq-0.6.1)63.
The count data were normalized using the Variance Stabilizing Transformation
(VST) function from the DESeq2 package64. Principal Component Analysis (PCA)
was performed on transformed read counts using the top 500 most variable genes
to assess the overall similarity between the samples. Differential gene expression
analysis between control and mutants was performed using DESeq2. Differentially
expressed genes were selected using a FDR-adjusted p-value cut-off < 0.01 and an
absolute log2 fold change > 0.5. Gene symbols were annotated using biomaRt
(BioConductor version 3.1). Gene ontology analysis was performed with the
DAVID Bioinformatics Resource (v6.7). Heat maps were generated with Morpheus
(Broad Institute) or the function heatmap.2 from the R package gplots.
Western blot analysis. Mouse lungs were perfused through the right ventricle
with cold PBS containing PhosSTOP (Roche) and dissected before snap freezing in
liquid nitrogen. Lungs were homogenized in lysis buffer (20 mM Tris-HCl pH 7.4,
1 mM EDTA, cOmplete ULTRA (Roche), PhosSTOP (Roche), 1% NP-40, 0.1%
SDS, 150 mM NaCl) with Pestle (ARgos) and clariﬁed by centrifugation at 20000 ×
g for 20 min at 4 °C. Total protein concentration in lysates was quantiﬁed using
Precision Red Advanced protein assay reagent (Cytoskeleton). Soluble supernatants
were prepared in SDS-PAGE sample buffer and analysed by SDS-polyacrylamide
gel electrophoresis and immunoblotting after loading 10–30 µg of total lung lysates.
Signals were detected with horseradish peroxidase-conjugated secondary antibodies
followed by ECL Prime or ECL detection reagent (GE Healthcare). The blots were
quantiﬁed with the gel analysis function in Fiji software65. The following antibodies
were used for immunoblotting: mouse anti-β-actin (sc-47778, Santa Cruz, 1:2000),
mouse anti-αSMA (A2547, Sigma, 1:1000), rabbit anti-Tropoelastin (ab21600,
abcam, 1:1000), rabbit anti-GAPDH (#2118, Cell Signaling, 1:1000), rabbit anti-
Phospho-HGF R/c-Met (Y1234/Y1235) (AF2480, R&D Systems, 1:500), mouse
anti-Met (#3127, Cell Signaling, 1:1000), mouse anti-Angiopoietin-1 (MAB923,
R&D Systems, 1:500), rabbit anti-Phospho-Tie-2 (Y992) (AF2720, R&D Systems,
1:500), goat anti-Tie-2 (AF762, R&D Systems, 1:2000), rabbit anti-YAP (#14074,
Cell Signaling, 1:1000), rabbit anti-TAZ (#4883, Cell Signaling, 1:1000), donkey
anti-Rabbit IgG, HRP-linked whole Ab (NA934, GE-Healthcare, 1:15000), sheep
anti-Mouse IgG, HRP-linked whole Ab (NA931, HG-Healthcare, 1:10000) and
Peroxidase AfﬁniPure Bovine anti-Goat IgG (H+ L) (805-035-180, Jackson
ImmunoResearch, 1:15000). Full blots are shown in Supplementary Fig. 9.
Quantitative RT-PCR analysis. Total RNA was isolated from ﬂow cytometrically
sorted or cultured cells using the RNeasy Plus Micro Kit (QIAGEN). 100 ng of
RNA per reaction for freshly sorted or 500 ng for cultured cells was used to gen-
erate complementary DNA with the iScript cDNA Synthesis Kit (BIO-RAD). The
quantitative PCR (qPCR) was performed on a CFX96 Touch Real-Time PCR
Detection System (BIO-RAD). The following FAM-conjugated TaqMan gene
expression probes (ThermoFisher) were used in combination with SsoAdvanced
Universal Probes Supermix (BIO-RAD): Pdgfrb (Mm00435546_m1), Pecam1
(Mm01242584_m1), Hgf (Mm01135184_m1), Met (Mm01156972_m1), Wnt11
(Mm00437327_g1), Tgfb2 (Mm00436955_m1), Bmp4 (Mm00432087_m1), Angpt1
(Mm00456503_m1), Tie1 (Mm00441786_m1), Tek (Mm00443254_m1), Angpt2
(Mm00545822_m1), Cspg4 (Mm00507257_m1), Notch3 (Mm01345646_m1),
Cldn5 (Mm00727012_s1). VIC-conjugated Actb (4352341E) TaqMan probe was
used to normalize gene expression. The following primer pairs were used in
combination with PowerUp SYBR Green Master Mix (ThermoFisher): Sftpc for-
ward (5’-ATGGACATGAGTAGCAAAGAGGT-3’), Sftpc reverse (5’-CACGAT-
GAGAAGGCGTTTGAG-3’), Actb forward (5’-ACTGCCGCATCCT
CTTCCTC-3’), Actb reverse (5’-CCGCTCGTTGCCAATAGTGA-3’). Actb was
used to normalize gene expression. Per group at least four mice from two inde-
pendent litters with triplicate reactions for each gene were analyzed to obtain the
relative expression differences using the 2-ΔΔCt method.
Statistical analysis. Statistical analysis was performed using Graphpad Prism
software or the R statistical environment (http://r-project.org). All data are pre-
sented as mean ± s.e.m. unless indicated otherwise. Data were tested for normal
distribution and unpaired two tailed student t-tests (if two samples have equal
variances) or Welch’s t-tests (if two samples have unequal variances) were used to
determine statistical signiﬁcance between two groups. For analysis of the statistical
signiﬁcance of differences between more than two groups, we performed one-way
ANOVA with Tukey’s multiple comparison tests to assess statistical signiﬁcance
with a 95% conﬁdence interval. P < 0.05 was considered signiﬁcant unless stated
otherwise. No statistical methods were used to predetermine sample size, which
was, instead, chosen according to previous experiments. All experiments were
performed independently at least three times unless noted otherwise in the
respective ﬁgure legends. If lungs were not properly inﬂated, those mice were
excluded from analysis. The experiments were not randomized and the investi-
gators were not blinded to allocation during experiments and outcome assessment.
Data availability. All relevant data supporting the results of the present study are
included within the article, its Supplementary Information ﬁles and can be
obtained from the corresponding authors upon reasonable request.
RNA sequencing data is available from the Gene Expression Omnibus (GEO)
database: GSE96748.
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